Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233–54.

Article  PubMed  Google Scholar 

Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022;7:262–74.

Article  PubMed  Google Scholar 

Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12–49.

Article  PubMed  Google Scholar 

Murphy N, Strickler HD, Stanczyk FZ, Xue X, Wassertheil-Smoller S, Rohan TE, Ho GY, Anderson GL, Potter JD, Gunter MJ. A prospective evaluation of endogenous sex hormone levels and colorectal Cancer risk in Postmenopausal Women. J Natl Cancer Inst. 2015;107:djv210.

Article  PubMed  PubMed Central  Google Scholar 

Razak S, Alam I, Afsar T, Abulmeaty MMA, Almajwal A, Jahan S. A Prospective Evaluation of Serum Vitamin D (1, 25(OH)(2) D(3)) and endogenous sex hormone levels in Colorectal Cancer patients. Front Oncol. 2019;9:468.

Article  PubMed  PubMed Central  Google Scholar 

Lin JH, Zhang SM, Rexrode KM, Manson JE, Chan AT, Wu K, Tworoger SS, Hankinson SE, Fuchs C, Gaziano JM, et al. Association between sex hormones and colorectal cancer risk in men and women. Clin Gastroenterol Hepatol. 2013;11:419–e424411.

Article  CAS  PubMed  Google Scholar 

Lavasani S, Chlebowski RT, Prentice RL, Kato I, Wactawski-Wende J, Johnson KC, Young A, Rodabough R, Hubbell FA, Mahinbakht A, Simon MS. Estrogen and colorectal cancer incidence and mortality. Cancer. 2015;121:3261–71.

Article  CAS  PubMed  Google Scholar 

Mori N, Sawada N, Iwasaki M, Yamaji T, Goto A, Shimazu T, Inoue M, Murphy N, Gunter MJ, Tsugane S. Circulating sex hormone levels and colorectal cancer risk in Japanese postmenopausal women: the JPHC nested case-control study. Int J Cancer. 2019;145:1238–44.

Article  CAS  PubMed  Google Scholar 

Mori N, Keski-Rahkonen P, Gicquiau A, Rinaldi S, Dimou N, Harlid S, Harbs J, Van Guelpen B, Aune D, Cross AJ, et al. Endogenous circulating sex hormone concentrations and Colon cancer risk in Postmenopausal women: a prospective study and Meta-analysis. JNCI Cancer Spectr. 2021;5:pkab084.

Article  PubMed  PubMed Central  Google Scholar 

Yang W, Giovannucci EL, Hankinson SE, Chan AT, Ma Y, Wu K, Fuchs CS, Lee IM, Sesso HD, Lin JH, Zhang X. Endogenous sex hormones and colorectal cancer survival among men and women. Int J Cancer. 2020;147:920–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rebecca J, Rodabough, Rosenberg CA, Taylor VM, Harris R, Chen C, et al. Estrogen plus Progestin and Colorectal Cancer in Postmenopausal Women. N Engl J Med. 2004;350:991–1004.

Article  CAS  PubMed  Google Scholar 

Tian Y, Lin Y, Qu C, Arndt V, Baurley JW, Berndt SI, Bien SA, Bishop DT, Brenner H, Buchanan DD, et al. Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk. Br J Cancer. 2024;130:1687–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amitay EL, Carr PR, Jansen L, Alwers E, Roth W, Herpel E, Kloor M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M. Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways. Int J Cancer. 2020;147:1018–26.

Article  CAS  PubMed  Google Scholar 

Thomas MP, Potter BV. The structural biology of oestrogen metabolism. J Steroid Biochem Mol Biol. 2013;137:27–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chauvin S, Cohen-Tannoudji J, Guigon CJ. Estradiol Signaling at the heart of Folliculogenesis: its potential deregulation in human ovarian pathologies. Int J Mol Sci 2022, 23.

Acconcia F, Fiocchetti M, Marino M. Xenoestrogen regulation of ERalpha/ERbeta balance in hormone-associated cancers. Mol Cell Endocrinol. 2017;457:3–12.

Article  CAS  PubMed  Google Scholar 

Jia M, Dahlman-Wright K, Gustafsson JA. Estrogen receptor alpha and beta in health and disease. Best Pract Res Clin Endocrinol Metab. 2015;29:557–68.

Article  CAS  PubMed  Google Scholar 

Khan MZI, Uzair M, Nazli A, Chen JZ. An overview on estrogen receptors signaling and its ligands in breast cancer. Eur J Med Chem. 2022;241:114658.

Article  CAS  PubMed  Google Scholar 

Rawluszko-Wieczorek AA, Romanowska K, Nowicki M. Chromatin modifiers - coordinators of estrogen action. Biomed Pharmacother 2022, 153.

Cerutti C, Shi J-R, Vanacker J-M. Multifaceted Transcriptional Network of Estrogen-Related Receptor Alpha in Health and Disease. Int J Mol Sci 2023, 24.

Arao Y, Korach KS. The physiological role of estrogen receptor functional domains. Essays Biochem. 2021;65:867–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 2013;34:309–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu YW, Gao H, Marstrand TT, Ström A, Valen E, Sandelin A, Gustafsson JÅ, Dahlman-Wright K. The genome landscape of ERα- and ERβ-binding DNA regionsvol 105, pg 2604, (2008). Proceedings of the National Academy of Sciences of the United States of America 2019, 116:1460–1461.

Song DD, He H, Indukuri R, Huang ZQ, Stepanauskaite L, Sinha I, Haldosen LA, Zhao CY, Williams C. ERα and ERβ homodimers in the same Cellular Context regulate distinct transcriptomes and functions. Front Endocrinol 2022, 13.

Mahboobifard F, Pourgholami MH, Jorjani M, Dargahi L, Amiri M, Sadeghi S, Tehrani FR. Estrogen as a key regulator of energy homeostasis and metabolic health. Biomed Pharmacother. 2022;156:113808.

Article  CAS  PubMed  Google Scholar 

Topi G, Satapathy SR, Dash P, Fred Mehrabi S, Ehrnström R, Olsson R, Lydrup ML, Sjölander A. Tumour-suppressive effect of oestrogen receptor β in colorectal cancer patients, colon cancer cells, and a zebrafish model. J Pathol. 2020;251:297–309.

Article  CAS  PubMed  Google Scholar 

Topi G, Ghatak S, Satapathy SR, Ehrnström R, Lydrup M-L, Sjölander A. Combined estrogen alpha and Beta receptor expression has a prognostic significance for Colorectal Cancer patients. Front Med 2022, 9.

Topi G, Satapathy SR, Ghatak S, Hellman K, Ek F, Olsson R, Ehrnström R, Lydrup M-L, Sjölander A. High oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer. Cell Communication Signal 2024, 22.

Liu T, Zhao M, Peng L, Chen J, Xing P, Gao P, Chen L, Qiao X, Wang Z, Di J et al. WFDC3 inhibits tumor metastasis by promoting the ERβ-mediated transcriptional repression of TGFBR1 in colorectal cancer. Cell Death Dis 2023, 14.

Giroux V, Bernatchez G, Carrier JC. Chemopreventive Effect of ERβ-Selective Agonist on Intestinal Tumorigenesis in mice. Mol Carcinog. 2011;50:359–69.

Article  CAS  PubMed  Google Scholar 

Arterburn JB, Prossnitz ER. G protein-coupled estrogen receptor GPER: molecular pharmacology and therapeutic applications. Annu Rev Pharmacol Toxicol. 2023;63:295–320.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma G, Mauvais-Jarvis F, Prossnitz ER. Roles of G protein-coupled estrogen receptor GPER in metabolic regulation. J Steroid Biochem Mol Biol. 2018;176:31–7.

Article  CAS  PubMed  Google Scholar 

Prossnitz ER, Barton M. The G protein-coupled oestrogen receptor GPER in health and disease: an update. Nat Reviews Endocrinol. 2023;19:407–24.

Article  CAS  Google Scholar 

Hall KA, Filardo EJ. The G protein-coupled estrogen receptor (GPER): a critical therapeutic target for Cancer. Cells 2023, 12.

Lu L, Zhang Q, Shen X, Zhen P, Marin A, Garcia-Milian R, Roper J, Khan SA, Johnson CH. Asparagine synthetase and G-protein coupled estrogen receptor are critical responders to nutrient supply in KRAS mutant colorectal cancer. bioRxiv 2023.

Liu Q, Chen Z, Jiang G, Zhou Y, Yang X, Huang H, Liu H, Du J, Wang H. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer. Mol Cancer. 2017;16:87.

Article  PubMed  PubMed Central  Google Scholar 

Abancens M, Harvey BJ, McBryan J. GPER Agonist G1 prevents wnt-Induced JUN Upregulation in HT29 Colorectal Cancer cells. Int J Mol Sci 2022, 23.

Bustos V, Nolan ÁM, Nijhuis A, Harvey H, Parker A, Poulsom R, McBryan J, Thomas W, Silver A, Harvey BJ. GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions. Oncotarget. 2017;8:84258–75.

Article  PubMed  PubMed Central  Google Scholar 

Gilligan LC, Rahman HP, Hewitt AM, Sitch AJ, Gondal A, Arvaniti A, Taylor AE, Read ML, Morton DG, Foster PA. Estrogen activation by Steroid Sulfatase increases Colorectal Cancer Proliferation via GPER. J Clin Endocrinol Metab. 2017;102:4435–47.